A Review of Deep Learning Methods for Antibodies
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Driven by its successes across domains such as computer vision and natural language processing, deep learning has recently entered the field of biology by aiding in cellular image classification, finding genomic connections, and advancing drug discovery. In drug discovery and protein engineering, a major goal is to design a molecule that will perform a useful function as a therapeutic drug. Typically, the focus has been on small molecules, but new approaches have been developed to apply these same principles of deep learning to biologics, such as antibodies. Here we give a brief background of deep learning as it applies to antibody drug development, and an in-depth explanation of several deep learning algorithms that have been proposed to solve aspects of both protein design in general, and antibody design in particular.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mastering the game of Go with deep neural networks and tree search
Silver, D., Huang, A., Maddison, C. J., Guez, A., Sifre, L., van den Driessche, G., Schrittwieser, J., Antonoglou, I., Panneershelvam, V., Lanctot, M., et al. (2016) · Nature · doi:10.1038/nature16961 · Cited by 15,612
HMMER web server: interactive sequence similarity searching
Finn, R. D., Clements, J., & Eddy, S. R. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr367 · Cited by 5,952
Geometric Deep Learning: Going beyond Euclidean data
Bronstein, M. M., Bruna, J., LeCun, Y., Szlam, A., & Vandergheynst, P. (2017) · IEEE Signal Processing Magazine · doi:10.1109/msp.2017.2693418 · Cited by 3,661 · cited 1×
“In recent years, solutions to computer vision problems have seen significant increases in success due to geometric deep learning and convolutional neural networks [22,23].”
BackgroundImproved protein structure prediction using potentials from deep learning
Senior, A. W., Evans, R., Jumper, J., Kirkpatrick, J., Sifre, L., Green, T., Qin, C., Žídek, A., Nelson, A. W. R., Bridgland, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1923-7 · Cited by 3,378
Learning Phrase Representations using RNN Encoder-Decoder for Statistical Machine Translation
Cho, K., van Merrienboer, B., Gulcehre, C., Bahdanau, D., Bougares, F., Schwenk, H., & Bengio, Y. (2014) · arXiv · doi:10.48550/arxiv.1406.1078 · Cited by 3,317
One Pixel Attack for Fooling Deep Neural Networks
Su, J., Vargas, D. V., & Sakurai, K. (2019) · IEEE Transactions on Evolutionary Computation · doi:10.1109/tevc.2019.2890858 · Cited by 2,406
ZDOCK: An initial‐stage protein‐docking algorithm
Chen, R., Li, L., & Weng, Z. (2003) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.10389 · Cited by 1,393 · cited 1×
“To generate these negative examples, the authors use a fast-Fourier transform (FFT)-based docking algorithm, ZDOCK, to select incorrect docking solutions from the set of sampled conformations [13].”
MethodMachine Learning for Molecular Simulation
Noé, F., Tkatchenko, A., Müller, K.-R., & Clementi, C. (2020) · Annual Review of Physical Chemistry · doi:10.1146/annurev-physchem-042018-052331 · Cited by 956
Reliable B cell epitope predictions: impacts of method development and improved benchmarking
Kringelum, J. V., Lundegaard, C., Lund, O., & Nielsen, M. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002829 · Cited by 697 · cited 1×
“Despite being theorized as an unsolvable problem, several methods have been proposed and claim moderate success [21].”
BackgroundDeep learning for molecular design—a review of the state of the art
Elton, D. C., Boukouvalas, Z., Fuge, M. D., & Chung, P. W. (2019) · Molecular Systems Design & Engineering · doi:10.1039/c9me00039a · Cited by 683 · cited 1×
“For example, deep learning applications in small molecule design benefit from commonly used benchmarking datasets such as ZINC and ChEMBL and image-based deep learning methods are often evaluated on MNIST or ImageNet [69,70].”
Method
Cited by
Deep Learning in Protein Structural Modeling and Design
Gao, W., Mahajan, S. P., Sulam, J., & Gray, J. J. (2020) · Patterns · doi:10.1016/j.patter.2020.100142 · Cited by 227
Antibody structure prediction using interpretable deep learning
Ruffolo, J. A., Sulam, J., & Gray, J. J. (2022) · Patterns · doi:10.1016/j.patter.2021.100406 · Cited by 216
DLAB-deep learning methods for structure-based virtual screening of antibodies
Schneider, C., Buchanan, A., Taddese, B., & Deane, C. M. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btab660 · Cited by 102
In silico proof of principle of machine learning-based antibody design at unconstrained scale
Akbar, R., Robert, P. A., Weber, C. R., Widrich, M., Frank, R., Pavlović, M., Scheffer, L., Chernigovskaya, M., Snapkov, I., Slabodkin, A., et al. (2022) · mAbs · doi:10.1080/19420862.2022.2031482 · Cited by 94
Success stories of AI in drug discovery - where do things stand?
Mak, K.-K., Balijepalli, M. K., & Pichika, M. R. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.1985108 · Cited by 51
Metadata
- Authors
- Graves, J., Byerly, J., Priego, E., Makkapati, N., Parish, S., Medellin, B., & Berrondo, M.
- Venue
- Antibodies
- Publisher
- MDPI AG
- Published
- 2020-04-28
- Volume
- 9
- Issue
- 2
- Pages
- 12
- ISSN
- 2073-4468 (ISSN-L)
- OpenAlex
- W3022788428
- Cited by
- 72
- References
- 23
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Review of Deep Learning Methods for Antibodies. https://app.cochat.ai/papers/10.3390/antib9020012
- The paper
- Graves, J., Byerly, J., Priego, E., Makkapati, N., Parish, S., Medellin, B., & Berrondo, M. (2020). A Review of Deep Learning Methods for Antibodies. Antibodies. https://doi.org/10.3390/antib9020012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.